It has been demonstrated that PD-L1+ cells are positively correlated with IL-35+ cells in non-small cell lung cancer [24], and the activation of the PD-L1/PD-1 pathway increased the expression of IL-35 in PBMC [25]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.